AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2026 Issue 1; Ask the Editor
Adverse Effects of Injectable Non-Insulin Antidiabetic Drug
A patient with prediabetes presents to the emergency room with complaints of nausea, vomiting, and epigastric abdominal pain. In the final diagnosis, the provider documented drug-induced acute pancreatitis without infection or necrosis due to Ozempic. Is it appropriate to assign code T38.3X5A, Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter, for the adverse effect of this injectable medication? ...
Subscribe or sign in to view the full article.
Article Overview
This Find-A-Code article explains how to think about an adverse drug effect scenario involving an injectable non-insulin antidiabetic medication in an emergency setting. It is intended for coders and compliance-minded billing staff who need to understand the relevant diagnosis coding framework, the code sets involved, and the general documentation considerations discussed in the article.
Why This Topic Matters
Accurate reporting of adverse effects depends on matching the documented drug reaction with the correct diagnosis coding structure. This article matters because it helps readers evaluate a common real-world scenario involving an injectable antidiabetic medication and related acute pancreatitis documentation.
What You Will Learn
- How the article frames an adverse effect scenario involving an injectable antidiabetic medication
- Which diagnosis code set is relevant to the discussion
- How the article approaches the relationship between the documented drug reaction and the reported diagnosis
- What documentation context is considered in the emergency room example
Who Should Read This
- Medical coders
- Coding auditors
- Billing staff
- Compliance teams
- Revenue cycle professionals
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com